Plasma Copeptin and Risk of Lower-Extremity Amputation in Type 1 and Type 2 Diabetes

OBJECTIVE: Diabetes is the leading cause of nontraumatic lower-extremity amputations (LEAs). Identification of patients with foot ulcers at risk for amputation remains clinically challenging. Plasma copeptin, a surrogate marker of vasopressin, is associated with the risk of cardiovascular and renal...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Diabetes Care
Main Authors: Potier, Louis, Roussel, Ronan, Marre, Michel, Bjornstad, Petter, Cherney, David Z., El Boustany, Ray, Fumeron, Frédéric, Venteclef, Nicolas, Gautier, Jean-François, Hadjadj, Samy, Mohammedi, Kamel, Velho, Gilberto
Formato: Artigo
Idioma:Inglês
Publicado em: American Diabetes Association 2019
Assuntos:
Pathophysiology/Complications
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6973542/
https://ncbi.nlm.nih.gov/pubmed/31582427
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/dc19-1062
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados